Learn More
Medchemexpress LLC Ebvaciclib 25mg | 2185857-97-8 | 25 MG

Supplier: Medchemexpress LLC HY11417725MG
Ebvaciclib is a selective, orally bioavailable inhibitor of cyclin-dependent kinases CDK2, CDK4, and CDK6 that induces cell cycle arrest and apoptosis in preclinical tumor models. The compound shows sub-nanomolar to low-nanomolar binding affinity and is supplied as a high-purity research reagent with recommended solvent and formulation guidance for in vitro and in vivo studies.
- Selective inhibitor of CDK2, CDK4, and CDK6.
- Orally bioavailable and active in cellular assays.
- High potency with sub-nanomolar to low-nanomolar affinity.
- Supplied at high purity for research applications.
- Soluble in DMSO; example in vivo formulations provided.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.